Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products-Reference-Cited by-同舟云学术

Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products

Published:2008-04 Issue:1-2 Volume:333 Page:1-9
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Koren Eugen,Smith Holly W.,Shores Elizabeth,Shankar Gopi,Finco-Kent Deborah,Rup Bonita,Barrett Yu-Chen,Devanarayan Viswanath,Gorovits Boris,Gupta Shalini,Parish Thomas,Quarmby Valerie,Moxness Michael,Swanson Steven J.,Taniguchi Gary,Zuckerman Linda A.,Stebbins Christopher C.,Mire-Sluis Anthony

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference30 articles.

1. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease;Baert;N. Engl. J. Med.,2003

2. Immunogenicity, efficacy and adverse events of adalimumab in RA patients;Bender;Rheumatol. Int.,2007

3. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoietin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project;Bennett;Blood,2005

4. Increased IgA antibodies to cytokeratins in the spondyloarthropaties;Borg;Ann. Rheum. Dis.,1994

5. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin;Casadevall;N. Engl. J. Med.,2002

Cited by 292 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of Atezolizumab: Influence of Testing Method and Sampling Frequency on Reported Anti-drug Antibody Incidence Rates;The AAPS Journal;2024-07-15

2. T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeutics;mAbs;2024-03-21

3. Strategy and Validation of a Nonclinical Generic Plug-and-Play Antidrug Antibody Method for Human Monoclonal Antibody Biotherapeutics;Bioanalysis;2024-02-09

4. Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies;BioDrugs;2024-01-23

5. Preclinical Development of Monoclonal Antibodies;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024